Infectious Diseases Institute
The Infectious Diseases Institute (IDI), Uganda, is one of the recruiting sites for the DolPHIN 2 trial. It is responsible for local coordination and implementation of the trial in Uganda as well as pharmacoeconomic research into the implementation of dolutegravir.
IDI is a Ugandan not-for-profit organisation whose Mission is to strengthen health systems in Africa, with a strong emphasis on infectious diseases, through research and capacity development. Established within Makerere University, the Institute began life in 2002 and currently provides care and treatment services to over 100,000 people living with HIV in urban and rural settings in Uganda which amounts to about 10% of the national effort. IDI also provides extensive prevention services and is a national referral centre for complicated cases of HIV.